Expert: Health Canada approves updated COVID-19 vaccine ahead of holidays
Amidst the onset of respiratory illnesses this flu season, Canada has fortified its defences against the persistent threat of COVID-19 with the approval of another vaccine. Health Canada on December 5 approved the updated Novavax vaccine, marking the third updated booster available to Canadians alongside those from Pfizer and Moderna. ()Ìý
Here is an expert from ±«ÓãÖ±²¥ who can provide comment on this topic:Â
Anne Gatignol, Full Professor, Department of Medicine, Division of Experimental MedicineÂ
“Coronavirus Omicron XBB subvariants are circulating widely across Canada. The XBB-updated vaccines from Moderna and Pfizer based on mRNA technology were approved in September. An XBB-updated protein-based vaccine from Novavax is now approved by Health Canada. It gives an additional option to individuals who do not want or cannot receive an mRNA vaccine.â€Â  Â
Anne Gatignol is Full Professor in the Department of Medicine and an Associate Member of the Department of Microbiology and Immunology. She investigates virus-cell interactions to understand innate immune pathways during viral infections. Her lab also develops RNA therapies against HIV and Coronaviruses. Â
anne.gatignol [at] mcgill.ca (English, French)Ìý